Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) in serum and plasma.
Enzyme immunoassay for the quantitative determination of omalizumab (Xolair®) in serum and plasma. Matriks Biotek® omalizumab ELISA has been especially developed for the quantitative analysis omalizumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus..
|Required Volume (µl)||5|
|Total Time (min)||70|
|Dedection Limit (ng/mL)||0,01|
|Spike Recovery (%)||97|
|Shelf Life (year)||1|